Bloom Energy Stock Faces Key Risks as Growth Fuels S&P 500 Index Inclusion
Bloom Energy jumped to a crucial resistance level as its revenue growth fueled its upcoming inclusion to the S&P 500 Index.
Economy · News reference
Why Is Bloom Energy Stock Surging on Friday?
Bloom Energy Corp. (NYSE: TEL) stock rises Friday amid speculation over S&P 500 index inclusion and lower U.S. Treasury yields.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Bloom Energy, Illumina, and Everpure Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400, and S&P SmallCap 600
https://www.spglobal.com/spdji/en//documents/indexnews/announcements/20260904-1484999/1484999_shuffle5461-sept2026.pdf
I'm Calling It: Bloom Energy's Revenue Guidance Will Keep Surprising Wall Street Through Year-End
Bloom Energy, a fuel cell manufacturer, has raised its full-year revenue guidance to $3.9-$4.2 billion (up from $3.4-$3.8 billion) driven by surging demand for AI data center power solutions. With Q2 revenue reaching $1.0 billion and expanding partnerships with Oracle and MiTAC, the company is well-positioned to continue delivering positive surprises through year-end as AI infrastructure investments remain robust.
What's Going on With Salesforce Stock on Friday?
Salesforce stock dipped on Friday due to profit-taking following a historic rally driven by Q2 earnings, raised guidance and Claudeforce.
Fluoropolymer Tubing Industry Insights Report 2026: Total Revenue to Grow by $350 Million Reaching $1.13 Billion by 2032
The global fluoropolymer tubing market is projected to grow from $757.36 million in 2026 to $1.13 billion by 2032, at a CAGR of 6.85%. Growth is driven by demand from semiconductor, medical, pharmaceutical, battery, and aerospace industries, with opportunities emerging from high-purity requirements, miniaturization, and regulatory compliance. AI-enabled manufacturing and advanced extrusion technologies are enhancing production efficiency and quality control.
Why Is Tempus AI Stock Gaining Thursday?
Tempus AI (TEM) trades higher after positive Phase 3 mRNA cancer trial results spotlight its $1.5B acquisition of Personalis.